We are live on
!
Find out more
iBio
IBIO
IBIO
9 hedge funds and large institutions have $581K invested in iBio in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% less ownership
Funds ownership: 0% → 0% (-0%)
10% less funds holding
Funds holding: 10 → 9 (-1)
24% less capital invested
Capital invested by funds: $767K → $581K (-$186K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$17.3K |
| 3 |
CM
Churchill Management
Los Angeles,
California
|
+$8.65K |
| 4 |
GHA
GW Henssler & Associates
Kennesaw,
Georgia
|
+$8.65K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$56K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$36K |
| 3 |
Citigroup
New York
|
-$2.16K |
| 4 |
Morgan Stanley
New York
|
-$2.16K |